ARTICLE

FindCenter AddIcon

Opening Up the Future of Psychedelic Science

By Thomas Anderson and Rotem Petranker — 2018

There is a growing research literature suggesting psychedelics hold incredible promise for treating mental health ailments ranging from depression and anxiety to PTSD. But how do we know for sure?

Read on theconversation.com

FindCenter Post-Image

Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents

Taken together, our results suggest that psychedelic microdosing may alleviate symptoms of mood and anxiety disorders, though the potential hazards of this practice warrant further investigation.

FindCenter AddIcon
FindCenter Post-Image

DMT Alters Cortical Travelling Waves

These results support a recent model proposing that psychedelics reduce the ‘precision-weighting of priors’, thus altering the balance of top-down versus bottom-up information passing.

FindCenter AddIcon
FindCenter Post-Image

The Trip Treatment

Research into psychedelics, shut down for decades, is now yielding exciting results.

FindCenter AddIcon
FindCenter Post-Image

UFC Eyes Psychedelics as Therapy for Fighters’ Brain Injuries

Last month, Ian McCall told HBO’s Real Sports that his 17 years in mixed martial arts led him to a painkiller addiction. “I was medicated and so numbed out from such a young age, I turned into a monster,” he told correspondent David Scott.

FindCenter AddIcon
FindCenter Post-Image

Psychedelic Drugs Can Help Treat PTSD Caused by Racism, Discrimination: Researchers

Williams is the co-lead author of a recent retrospective study that found those who tried doses of psilocybin (more commonly known as magic mushrooms), LSD, or MDMA (the pure substance found in Ecstasy or Molly) reported a decrease in trauma symptoms, depression and anxiety after 30 days.

FindCenter AddIcon
FindCenter Post-Image

How Ecstasy and Psilocybin Are Shaking Up Psychiatry

Regulators will soon grapple with how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.

FindCenter AddIcon
FindCenter Post-Image

MDMA Lauded as ‘Breakthrough’ Therapy for PTSD Patients

The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.

FindCenter AddIcon
FindCenter Post-Image

The Interview: MDMA-Therapy Expert Dr. Rick Doblin

The world’s leading advocate for the medicinal use of psychedelics on the ghost of Timothy Leary, why Ecstasy could cure PTSD, and the best place to trip in Boston.

FindCenter AddIcon
FindCenter Post-Image

Johns Hopkins Scientists Give Psychedelics the Serious Treatment

Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been steadily making their way back into the lab for a revamped 21st-century-style look.

FindCenter AddIcon
FindCenter Post-Image

Can Psychedelic Experiences Cure Alcohol Addiction?

A new study hints at a novel and promising treatment for alcohol use disorder.

FindCenter AddIcon

EXPLORE TOPIC

Psychedelic Research